{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:07:00Z","timestamp":1780492020962,"version":"3.54.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,3,26]],"date-time":"2014-03-26T00:00:00Z","timestamp":1395792000000},"content-version":"vor","delay-in-days":390,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"crossref","award":["F32 HS019178"],"award-info":[{"award-number":["F32 HS019178"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"crossref","award":["DK085446"],"award-info":[{"award-number":["DK085446"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"crossref","award":["AG037593"],"award-info":[{"award-number":["AG037593"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.jacc.2012.12.034","type":"journal-article","created":{"date-parts":[[2013,3,18]],"date-time":"2013-03-18T17:03:06Z","timestamp":1363626186000},"page":"1250-1258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Cost-Effectiveness of Statins for Primary Cardiovascular Prevention in Chronic Kidney Disease"],"prefix":"10.1016","volume":"61","author":[{"given":"Kevin F.","family":"Erickson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohan","family":"Japa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas K.","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn M.","family":"Chertow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan M.","family":"Garber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy D.","family":"Goldhaber-Fiebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2012.12.034_bib1","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2012.12.034_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.7326\/0003-4819-141-2-200407200-00007","article-title":"The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency","volume":"141","author":"Hsu","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2012.12.034_bib3","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1681\/ASN.V133745","article-title":"Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States","volume":"13","author":"Muntner","year":"2002","journal-title":"J Am Soc Nephroly"},{"key":"10.1016\/j.jacc.2012.12.034_bib4","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.12.034_bib5","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstrom","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.12.034_bib6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.12.034_bib7","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jacc.2010.01.020","volume":"55","author":"Ridker","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.034_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.12.034_bib9","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/01.CIR.0000143892.84582.60","article-title":"Effect of pravastatin on cardiovascular events in people with chronic kidney disease","volume":"110","author":"Tonelli","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.12.034_bib10","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.jacc.2007.11.072","article-title":"Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study","volume":"51","author":"Shepherd","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.034_bib11","article-title":"HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis","author":"Navaneethan","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2012.12.034_bib12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7326\/0003-4819-157-4-201208210-00007","article-title":"Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis","volume":"157","author":"Palmer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2012.12.034_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.7326\/0003-4819-157-4-201208210-00005","article-title":"Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis","volume":"157","author":"Upadhyay","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2012.12.034_bib14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.7326\/0003-4819-138-2-200301210-00010","article-title":"Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency","volume":"138","author":"Tonelli","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2012.12.034_bib15","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.12.034_bib16","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jclinepi.2006.11.006","article-title":"Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population","volume":"60","author":"McClure","year":"2007","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jacc.2012.12.034_bib17","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jacc.2004.07.002","volume":"44","author":"Antman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.034_bib18","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2012.12.034_bib19","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2012.12.034_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1053\/j.ajkd.2006.09.017","article-title":"The impact of reclassifying moderate CKD as a coronary heart disease risk equivalent on the number of US adults recommended lipid-lowering treatment","volume":"49","author":"Hyre","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2012.12.034_bib21","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.1996.03540150055031","article-title":"Recommendations of the Panel on Cost-effectiveness in Health and Medicine","volume":"276","author":"Weinstein","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2012.12.034_bib22","first-page":"1","article-title":"United States Life Tables, 2006","volume":"58","author":"Arias","year":"2010","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.jacc.2012.12.034_bib23","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1161\/CIRCULATIONAHA.110.947960","article-title":"Cost-effectiveness of using high-sensitivity C-reactive protein to identify intermediate- and low-cardiovascular-risk individuals for statin therapy","volume":"122","author":"Lee","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.12.034_bib24","series-title":"Retail Prescription Program Drug List","year":"2012"},{"key":"10.1016\/j.jacc.2012.12.034_bib25","series-title":"Prices for Pravastatin","year":"2012"},{"key":"10.1016\/j.jacc.2012.12.034_bib26","series-title":"Clinical Laboratory Fee Schedule","year":"2010"},{"key":"10.1016\/j.jacc.2012.12.034_bib27","series-title":"Physician Fee Schedule","year":"2011"},{"key":"10.1016\/j.jacc.2012.12.034_bib28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCULATIONAHA.104.517565","article-title":"Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease","volume":"112","author":"Tonelli","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.12.034_bib29","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1001\/jama.2011.860","article-title":"Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis","volume":"305","author":"Preiss","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2012.12.034_bib30","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/clc.20758","article-title":"The association of statin use and statin type and cognitive performance: analysis of the Reasons for Geographic And Racial Differences in Stroke (REGARDS) study","volume":"33","author":"Glasser","year":"2010","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2012.12.034_bib31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.12.034_bib32","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0002-9149(96)00863-6","article-title":"Baseline risk factors and their association with outcome in the West of Scotland Coronary Prevention Study","volume":"79","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2012.12.034_bib33","doi-asserted-by":"crossref","first-page":"769","DOI":"10.7326\/0003-4819-132-10-200005160-00002","article-title":"Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics","volume":"132","author":"Prosser","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2012.12.034_bib34","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1136\/bmj.312.7044.1443","article-title":"Cost effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: life table method applied to health authority population","volume":"312","author":"Pharoah","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2012.12.034_bib35","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/ndt\/15.2.218","article-title":"Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure","volume":"15","author":"Schwarz","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2012.12.034_bib36","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hec.790","article-title":"Illustrating the impact of including future costs in economic evaluations: an application to end-stage renal disease care","volume":"12","author":"Manns","year":"2003","journal-title":"Health Econ"},{"key":"10.1016\/j.jacc.2012.12.034_bib37","series-title":"Statin Drugs to Treat High Cholesterol and Heart Disease","year":"2010"},{"key":"10.1016\/j.jacc.2012.12.034_bib38","series-title":"Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States","year":"2011"},{"key":"10.1016\/j.jacc.2012.12.034_bib39","doi-asserted-by":"crossref","first-page":"563","DOI":"10.7326\/0003-4819-137-7-200210010-00007","article-title":"Acute myocardial infarction and renal dysfunction: a high-risk combination","volume":"137","author":"Wright","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2012.12.034_bib40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/0272989X9301300202","article-title":"The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors","volume":"13","author":"Fryback","year":"1993","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jacc.2012.12.034_bib41","first-page":"861","article-title":"Utilization of acute care services in the year before and after first stroke: a population-based study","volume":"46","author":"Leibson","year":"1996","journal-title":"Neurology"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109713002623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109713002623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:57:30Z","timestamp":1760014650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109713002623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0735109713002623"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2012.12.034","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness of Statins for Primary Cardiovascular Prevention in Chronic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2012.12.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}